ロード中...
Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer
Basal-like breast cancer is an aggressive disease with limited therapeutic options because these tumors frequently express the ‘triple-negative’ phenotype. We have recently reported that inducible nitric oxide synthase (NOS2) is a strong predictor of survival in patients with estrogen receptor negat...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3380363/ https://ncbi.nlm.nih.gov/pubmed/21893353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2011.07.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|